Scalable Drug Product Manufacturing

Quotient Sciences specializes in guiding drug products through the critical transition from late-stage optimization to full commercial readiness, focusing on scalable drug product manufacturing. Their approach is founded on rigorous science, regulatory alignment, and operational flexibility, ensuring drug product manufacturing is fully compliant and prepared for an accelerated commercial launch.

They offer commercial manufacturing solutions tailored to program needs, accommodating a variety of solid oral dosage form designs. Batch sizes are flexible, ranging from less than 1kg to over 400 kg. The company has a proven track record in niche market areas, including oncology, orphan/rare diseases, and pediatric indications, aiming to get products to patients faster. The facilities support global commercial markets like the US (FDA), Europe (EMA), and Japan (PMDA).

Discover how a robust, flexible manufacturing strategy can support your drug product scale-up and commercial launch.